Hodgkin Lymphoma: the Changing Role of Radiation Therapy in Early-Stage Disease—the Role of Functional Imaging.

about

Racial and Ethnic Disparities in the Pediatric Hodgkin Lymphoma Population.

P2860

Q40367333-AC2D5B84-7955-46BE-9E13-BE2B7EBC4753

P2860

Hodgkin Lymphoma: the Changing Role of Radiation Therapy in Early-Stage Disease—the Role of Functional Imaging.

Item

http://www.wikidata.org/entity/Q38549745

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Hodgkin Lymphoma: the Changing ...... he Role of Functional Imaging.

@en

type

Item

label

Hodgkin Lymphoma: the Changing ...... he Role of Functional Imaging.

@en

prefLabel

Hodgkin Lymphoma: the Changing ...... he Role of Functional Imaging.

@en

P1476

Hodgkin Lymphoma: the Changing ...... he Role of Functional Imaging.

@en

P2093

David J Iberri

http://www.w3.org/2001/XMLSchema#string

Ranjana H Advani

http://www.w3.org/2001/XMLSchema#string

Richard T Hoppe

http://www.w3.org/2001/XMLSchema#string

P2860

The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease

Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data Base.

Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study.

Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale

ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.

Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease.

Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.

P2888

s11864-015-0360-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11864-015-0360-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1051958455

http://www.w3.org/2001/XMLSchema#string

P698

26187795

http://www.w3.org/2001/XMLSchema#string

Hodgkin Lymphoma: the Changing Role of Radiation Therapy in Early-Stage Disease—the Role of Functional Imaging.

about

P2860

P2860

Hodgkin Lymphoma: the Changing Role of Radiation Therapy in Early-Stage Disease—the Role of Functional Imaging.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698